{"id":"https://openalex.org/W2053488031","doi":"https://doi.org/10.1016/j.clpt.2005.02.004","title":"A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data","display_name":"A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data","publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2053488031","doi":"https://doi.org/10.1016/j.clpt.2005.02.004","mag":"2053488031","pmid":"https://pubmed.ncbi.nlm.nih.gov/15961988"},"language":"en","primary_location":{"id":"doi:10.1016/j.clpt.2005.02.004","doi":"https://doi.org/10.1016/j.clpt.2005.02.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clpt.2005.02.004","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008224959","display_name":"Dani\u00ebl Martijn Jonker","orcid":"https://orcid.org/0000-0002-8227-9361","observed_orcids":["https://orcid.org/0000-0002-8227-9361"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"D JONKER","raw_affiliation_strings":["Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Sweden. daniel.jonker@farmbio.uu.se","Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Sweden. daniel.jonker@farmbio.uu.se","institution_ids":["https://openalex.org/I123387679"]},{"raw_affiliation_string":"Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011397220","display_name":"Leslie A. Kenna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"L KENNA","raw_affiliation_strings":["Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113829375","display_name":"Derek J. Leishman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"D LEISHMAN","raw_affiliation_strings":["Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R WALLIS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"R WALLIS","raw_affiliation_strings":["Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058236091","display_name":"Paul J. Milligan","orcid":"https://orcid.org/0000-0003-3430-3395","observed_orcids":["https://orcid.org/0000-0003-3430-3395"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"P MILLIGAN","raw_affiliation_strings":["Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011289806","display_name":"E. Niclas Jonsson","orcid":"https://orcid.org/0000-0002-2615-0280","observed_orcids":["https://orcid.org/0000-0002-2615-0280"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"E JONSSON","raw_affiliation_strings":["Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5008224959"],"corresponding_institution_ids":["https://openalex.org/I123387679"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.5952,"has_fulltext":false,"cited_by_count":84,"citation_normalized_percentile":{"value":0.89786908,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"77","issue":"6","first_page":"572","last_page":"582"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dofetilide","display_name":"dofetilide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.9620000123977661},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.8379999995231628},{"id":"https://openalex.org/keywords/class-iii-antiarrhythmic-drugs","display_name":"class III antiarrhythmic agents","score":0.8080000281333923},{"id":"https://openalex.org/keywords/torsades-de-pointes","display_name":"torsades de pointes","score":0.9190000295639038},{"id":"https://openalex.org/keywords/tolerance-development","display_name":"tolerance development","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C2779362680","wikidata":"https://www.wikidata.org/wiki/Q905000","display_name":"hERG","level":3,"score":0.9784796237945557},{"id":"https://openalex.org/C2777796741","wikidata":"https://www.wikidata.org/wiki/Q3712521","display_name":"Dofetilide","level":3,"score":0.9720615148544312},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.7720102071762085},{"id":"https://openalex.org/C2780486423","wikidata":"https://www.wikidata.org/wiki/Q1625433","display_name":"Torsades de pointes","level":3,"score":0.7380349040031433},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6649681329727173},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.568691611289978},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5646876692771912},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.556240439414978},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5218592882156372},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43159565329551697},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.4223208427429199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3323667049407959},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06380560994148254},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000072237","descriptor_name":"ERG1 Potassium Channel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000889","descriptor_name":"Anti-Arrhythmia Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006329","descriptor_name":"Heart Conduction System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008955","descriptor_name":"Models, Cardiovascular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024642","descriptor_name":"Potassium Channels, Voltage-Gated","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D024642","descriptor_name":"Potassium Channels, Voltage-Gated","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D027682","descriptor_name":"Cation Transport Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D027682","descriptor_name":"Cation Transport Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clpt.2005.02.004","doi":"https://doi.org/10.1016/j.clpt.2005.02.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clpt.2005.02.004","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:15961988","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15961988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W48496034","https://openalex.org/W77045251","https://openalex.org/W182370232","https://openalex.org/W1503490505","https://openalex.org/W1504233060","https://openalex.org/W1538383751","https://openalex.org/W1555920164","https://openalex.org/W1857240286","https://openalex.org/W1963748793","https://openalex.org/W1972658106","https://openalex.org/W1985052140","https://openalex.org/W1999867272","https://openalex.org/W2001781050","https://openalex.org/W2009887763","https://openalex.org/W2027877139","https://openalex.org/W2047620467","https://openalex.org/W2060802584","https://openalex.org/W2066464642","https://openalex.org/W2066482395","https://openalex.org/W2067770236","https://openalex.org/W2082520477","https://openalex.org/W2085048839","https://openalex.org/W2087804212","https://openalex.org/W2113927644","https://openalex.org/W2133376208","https://openalex.org/W2136800311","https://openalex.org/W2152235428","https://openalex.org/W2168806904","https://openalex.org/W2254921239","https://openalex.org/W2314139393","https://openalex.org/W2329469494","https://openalex.org/W2411165678","https://openalex.org/W4406499722"],"related_works":["https://openalex.org/W1972658106","https://openalex.org/W2521798439","https://openalex.org/W2049162091","https://openalex.org/W2018987751","https://openalex.org/W1148458745","https://openalex.org/W1976692785","https://openalex.org/W4414445413","https://openalex.org/W2034172298","https://openalex.org/W2553267884","https://openalex.org/W2343673409"],"abstract_inverted_index":{"BACKGROUND:":[0],"QT":[1,52,140,187,205,244,258],"prolongation":[2,53,206,245,259],"is":[3],"an":[4,161],"important":[5],"biomarker":[6],"of":[7,21,30,51,69,85,107,121,125,132,154,160,165,182,207,224,257,274],"the":[8,36,49,57,78,82,108,122,130,151,158,177,186,234,255,268,272],"arrhythmia":[9],"torsades":[10],"de":[11],"pointes":[12],"and":[13,48,67,81,96,111,172,242,278],"appears":[14],"to":[15,19,34,128,138,203],"be":[16],"related":[17],"mainly":[18],"blockade":[20,47,201,241],"delayed":[22],"inward":[23],"cardiac":[24],"rectifier":[25],"potassium":[26,45,169],"currents.":[27],"The":[28,63,228],"aim":[29],"this":[31],"study":[32,197],"was":[33,87,115],"quantify":[35],"relationship":[37,235],"between":[38,236],"in":[39,54,64,73,89,109,112,117,162,237,260,275],"vitro":[40,65,110,163,238,276],"human":[41],"ether-a-go-go-related":[42],"gene":[43],"(hERG)":[44],"channel":[46,136,240,270],"magnitude":[50],"humans":[55,261],"for":[56,168,246,253,262],"class":[58],"III":[59],"antiarrhythmic":[60],"dofetilide.":[61,247],"METHODS:":[62],"affinity":[66],"activity":[68],"dofetilide":[70,86,155,175,217],"were":[71],"determined":[72],"recombinant":[74],"cell":[75],"cultures":[76],"expressing":[77],"hERG":[79,200,239,269],"channel,":[80],"QT-prolonging":[83],"effect":[84],"assessed":[88],"5":[90],"clinical":[91,243],"studies":[92],"(80":[93],"healthy":[94],"volunteers":[95],"17":[97],"patients":[98],"with":[99,147,221],"ischemic":[100],"heart":[101],"disease).":[102],"A":[103,143],"population":[104],"pharmacokinetic-pharmacodynamic":[105,231],"analysis":[106],"vivo":[113],"data":[114],"performed":[116],"NONMEM":[118],"by":[119],"use":[120],"operational":[123],"model":[124,146,232,249],"pharmacologic":[126],"agonism":[127],"estimate":[129],"efficiency":[131],"transduction":[133],"from":[134],"ion":[135],"binding":[137],"Fridericia-corrected":[139],"response.":[141],"RESULTS:":[142],"3-compartment":[144],"pharmacokinetic":[145,279],"first-order":[148],"absorption":[149],"characterized":[150],"time":[152],"course":[153],"concentrations.":[156],"On":[157],"basis":[159,273],"potency":[164],"5.13":[166],"ng/mL":[167],"current":[170,229],"inhibition":[171],"predicted":[173],"unbound":[174],"concentrations,":[176],"estimated":[178],"transducer":[179],"ratio":[180],"(tau)":[181],"6.2":[183],"suggests":[184],"that":[185,265],"response":[188],"plateaus":[189],"before":[190],"currents":[191],"are":[192],"fully":[193],"blocked.":[194],"In":[195],"our":[196],"population,":[198],"10%":[199],"corresponds":[202],"a":[204,222],"20":[208],"ms":[209],"(95%":[210],"confidence":[211],"interval,":[212],"12-32":[213],"ms).":[214],"With":[215],"long-term":[216],"administration,":[218],"tolerance":[219],"develops":[220],"half-life":[223],"4.7":[225],"days.":[226],"CONCLUSIONS:":[227],"mechanism-based":[230],"quantified":[233],"This":[248],"may":[250],"prove":[251],"valuable":[252],"assessing":[254],"risk":[256],"other":[263],"drugs":[264],"selectively":[266],"block":[267],"on":[271],"assays":[277],"properties.":[280]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}